220 related articles for article (PubMed ID: 22054309)
1. Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes.
Guan J; Wen B; Deng Y; Zhang K; Chen H; Wu X; Ruan L; Tan W
Virol J; 2011 Nov; 8():506. PubMed ID: 22054309
[TBL] [Abstract][Full Text] [Related]
2. Induction of broadly neutralising HCV antibodies in mice by integration-deficient lentiviral vector-based pseudotyped particles.
Deng Y; Guan J; Wen B; Zhu N; Chen H; Song J; Yang Y; Wang Y; Tan W
PLoS One; 2013; 8(4):e62684. PubMed ID: 23626846
[TBL] [Abstract][Full Text] [Related]
3. Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.
Chmielewska AM; Naddeo M; Capone S; Ammendola V; Hu K; Meredith L; Verhoye L; Rychlowska M; Rappuoli R; Ulmer JB; Colloca S; Nicosia A; Cortese R; Leroux-Roels G; Balfe P; Bienkowska-Szewczyk K; Meuleman P; McKeating JA; Folgori A
J Virol; 2014 May; 88(10):5502-10. PubMed ID: 24599994
[TBL] [Abstract][Full Text] [Related]
4. Induction of humoral and cellular immune responses against hepatitis C virus by vaccination with replicon particles derived from Sindbis-like virus XJ-160.
Zhu W; Fu J; Lu J; Deng Y; Wang H; Wei Y; Deng L; Tan W; Liang G
Arch Virol; 2013 May; 158(5):1013-9. PubMed ID: 23250650
[TBL] [Abstract][Full Text] [Related]
5. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
[TBL] [Abstract][Full Text] [Related]
6. Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines.
Singh S; Vedi S; Samrat SK; Li W; Kumar R; Agrawal B
PLoS One; 2016; 11(1):e0146404. PubMed ID: 26751211
[TBL] [Abstract][Full Text] [Related]
7. The novel replication-defective vaccinia virus (Tiantan strain)-based hepatitis C virus vaccine induces robust immunity in macaques.
Wen B; Deng Y; Chen H; Guan J; Chuai X; Ruan L; Kong W; Tan W
Mol Ther; 2013 Sep; 21(9):1787-95. PubMed ID: 23774793
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus.
Arribillaga L; de Cerio AL; Sarobe P; Casares N; Gorraiz M; Vales A; Bruna-Romero O; Borrás-Cuesta F; Paranhos-Baccala G; Prieto J; Ruiz J; Lasarte JJ
Vaccine; 2002 Dec; 21(3-4):202-10. PubMed ID: 12450695
[TBL] [Abstract][Full Text] [Related]
9. A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.
Swadling L; Capone S; Antrobus RD; Brown A; Richardson R; Newell EW; Halliday J; Kelly C; Bowen D; Fergusson J; Kurioka A; Ammendola V; Del Sorbo M; Grazioli F; Esposito ML; Siani L; Traboni C; Hill A; Colloca S; Davis M; Nicosia A; Cortese R; Folgori A; Klenerman P; Barnes E
Sci Transl Med; 2014 Nov; 6(261):261ra153. PubMed ID: 25378645
[TBL] [Abstract][Full Text] [Related]
10. [Immunogenicity and heterologous protection in mice with a recombinant adenoviral-based vaccine carrying a hepatitis C virus truncated NS3 and core fusion protein].
Guan J; Deng Y; Chen H; Yang Y; Wen B; Tan W
Bing Du Xue Bao; 2015 Jan; 31(1):7-13. PubMed ID: 25997323
[TBL] [Abstract][Full Text] [Related]
11. Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania.
Bakari M; Aboud S; Nilsson C; Francis J; Buma D; Moshiro C; Aris EA; Lyamuya EF; Janabi M; Godoy-Ramirez K; Joachim A; Polonis VR; Bråve A; Earl P; Robb M; Marovich M; Wahren B; Pallangyo K; Biberfeld G; Mhalu F; Sandström E
Vaccine; 2011 Oct; 29(46):8417-28. PubMed ID: 21864626
[TBL] [Abstract][Full Text] [Related]
12. Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: a dose and route conundrum.
Singh S; Vedi S; Li W; Samrat SK; Kumar R; Agrawal B
Vaccine; 2014 May; 32(23):2712-21. PubMed ID: 24631092
[TBL] [Abstract][Full Text] [Related]
13. A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques.
Capone S; Meola A; Ercole BB; Vitelli A; Pezzanera M; Ruggeri L; Davies ME; Tafi R; Santini C; Luzzago A; Fu TM; Bett A; Colloca S; Cortese R; Nicosia A; Folgori A
J Virol; 2006 Feb; 80(4):1688-99. PubMed ID: 16439526
[TBL] [Abstract][Full Text] [Related]
14. DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice.
Pancholi P; Perkus M; Tricoche N; Liu Q; Prince AM
J Virol; 2003 Jan; 77(1):382-90. PubMed ID: 12477843
[TBL] [Abstract][Full Text] [Related]
15. Enhanced cell immune responses to hepatitis C virus core by novel heterologous DNA prime/lambda nanoparticles boost in mice.
Saeedi A; Ghaemi A; Tabarraei A; Moradi A; Gorji A; Semnani S; Soleimanjahi H; Adli AH; Hosseini SY; Vakili MA
Virus Genes; 2014 Aug; 49(1):11-21. PubMed ID: 24752903
[TBL] [Abstract][Full Text] [Related]
16. The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes.
von Delft A; Donnison TA; Lourenço J; Hutchings C; Mullarkey CE; Brown A; Pybus OG; Klenerman P; Chinnakannan S; Barnes E
Vaccine; 2018 Jan; 36(2):313-321. PubMed ID: 29203182
[TBL] [Abstract][Full Text] [Related]
17. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.
Zhao HP; Sun JF; Li N; Sun Y; Wang Y; Qiu HJ
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):158-66. PubMed ID: 19411115
[TBL] [Abstract][Full Text] [Related]
18. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
[TBL] [Abstract][Full Text] [Related]
19. Adenoviruses vectored hepatitis C virus vaccine cocktails induce broadly specific immune responses against multi-genotypic HCV in mice.
Luo S; Zhang P; Wang Y; Huang Y; Ma X; Deng Q; Zou P; Wang C; Zhang L; Li Y; Fu Y; Li T; Li C
Biomed Pharmacother; 2024 Jan; 170():115901. PubMed ID: 38056238
[TBL] [Abstract][Full Text] [Related]
20. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J
Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
